High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients

T. Qian, X. Guo, Allan D Levi, Steven Vanni, R. T. Shebert, M. L. Sipski

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Study design: Prospective cohort study. Objective: Although Bracken et al have demonstrated a significant neuroprotective effect of high-dose intravenous (i.v.) methylprednisolone (MP) within 8 h post spinal cord injury (SCI), this practice has recently been challenged. We hypothesized it is possible that acute corticosteroid myopathy (ACM) may occur secondary to the MP. This pilot study was performed to test this hypothesis. Setting: University of Miami School of Medicine/Jackson Memorial Hospital, Miami VA Medical Center, FL, USA. Methods: Subjects included five nonpenetrating traumatic SCI patients, who received 24 h MP according to National Acute Spinal Cord Injury Studies (NASCIS) protocol, and three traumatic patients who suffered SCI and did not receive MP. Muscle biopsies and electromyography (EMG) were performed to determine if myopathic changes existed in these patients. Results: Muscle biopsies from the SCI patients who received 24 h of MP showed muscle damage consistent with ACM in four out of five cases. EMG studies demonstrated myopathic changes in the MP-treated patients. In the three patients who had SCI but did not receive MP, muscle biopsies were normal and EMGs did not reveal evidence of myopathy. Conclusion: Our data suggest that MP in the dose recommended by the NASCIS may cause ACM. If this is true, part of the improvement of neurological recovery showed in NASCIS may be only a recording of the natural recovery of ACM, instead of any protection that MP offers to the injured spinal cord.

Original languageEnglish
Pages (from-to)199-203
Number of pages5
JournalSpinal Cord
Volume43
Issue number4
DOIs
StatePublished - Apr 1 2005

Fingerprint

Methylprednisolone
Muscular Diseases
Spinal Cord Injuries
Adrenal Cortex Hormones
Muscles
Electromyography
Biopsy
Neuroprotective Agents
Spinal Cord
Cohort Studies
Medicine
Prospective Studies

Keywords

  • Methylprednisolone
  • Myopathy
  • Spinal cord injury

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. / Qian, T.; Guo, X.; Levi, Allan D; Vanni, Steven; Shebert, R. T.; Sipski, M. L.

In: Spinal Cord, Vol. 43, No. 4, 01.04.2005, p. 199-203.

Research output: Contribution to journalArticle

Qian, T. ; Guo, X. ; Levi, Allan D ; Vanni, Steven ; Shebert, R. T. ; Sipski, M. L. / High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. In: Spinal Cord. 2005 ; Vol. 43, No. 4. pp. 199-203.
@article{a9ef99f90d1f41d1ac44334d005da861,
title = "High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients",
abstract = "Study design: Prospective cohort study. Objective: Although Bracken et al have demonstrated a significant neuroprotective effect of high-dose intravenous (i.v.) methylprednisolone (MP) within 8 h post spinal cord injury (SCI), this practice has recently been challenged. We hypothesized it is possible that acute corticosteroid myopathy (ACM) may occur secondary to the MP. This pilot study was performed to test this hypothesis. Setting: University of Miami School of Medicine/Jackson Memorial Hospital, Miami VA Medical Center, FL, USA. Methods: Subjects included five nonpenetrating traumatic SCI patients, who received 24 h MP according to National Acute Spinal Cord Injury Studies (NASCIS) protocol, and three traumatic patients who suffered SCI and did not receive MP. Muscle biopsies and electromyography (EMG) were performed to determine if myopathic changes existed in these patients. Results: Muscle biopsies from the SCI patients who received 24 h of MP showed muscle damage consistent with ACM in four out of five cases. EMG studies demonstrated myopathic changes in the MP-treated patients. In the three patients who had SCI but did not receive MP, muscle biopsies were normal and EMGs did not reveal evidence of myopathy. Conclusion: Our data suggest that MP in the dose recommended by the NASCIS may cause ACM. If this is true, part of the improvement of neurological recovery showed in NASCIS may be only a recording of the natural recovery of ACM, instead of any protection that MP offers to the injured spinal cord.",
keywords = "Methylprednisolone, Myopathy, Spinal cord injury",
author = "T. Qian and X. Guo and Levi, {Allan D} and Steven Vanni and Shebert, {R. T.} and Sipski, {M. L.}",
year = "2005",
month = "4",
day = "1",
doi = "10.1038/sj.sc.3101681",
language = "English",
volume = "43",
pages = "199--203",
journal = "Spinal Cord",
issn = "1362-4393",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients

AU - Qian, T.

AU - Guo, X.

AU - Levi, Allan D

AU - Vanni, Steven

AU - Shebert, R. T.

AU - Sipski, M. L.

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Study design: Prospective cohort study. Objective: Although Bracken et al have demonstrated a significant neuroprotective effect of high-dose intravenous (i.v.) methylprednisolone (MP) within 8 h post spinal cord injury (SCI), this practice has recently been challenged. We hypothesized it is possible that acute corticosteroid myopathy (ACM) may occur secondary to the MP. This pilot study was performed to test this hypothesis. Setting: University of Miami School of Medicine/Jackson Memorial Hospital, Miami VA Medical Center, FL, USA. Methods: Subjects included five nonpenetrating traumatic SCI patients, who received 24 h MP according to National Acute Spinal Cord Injury Studies (NASCIS) protocol, and three traumatic patients who suffered SCI and did not receive MP. Muscle biopsies and electromyography (EMG) were performed to determine if myopathic changes existed in these patients. Results: Muscle biopsies from the SCI patients who received 24 h of MP showed muscle damage consistent with ACM in four out of five cases. EMG studies demonstrated myopathic changes in the MP-treated patients. In the three patients who had SCI but did not receive MP, muscle biopsies were normal and EMGs did not reveal evidence of myopathy. Conclusion: Our data suggest that MP in the dose recommended by the NASCIS may cause ACM. If this is true, part of the improvement of neurological recovery showed in NASCIS may be only a recording of the natural recovery of ACM, instead of any protection that MP offers to the injured spinal cord.

AB - Study design: Prospective cohort study. Objective: Although Bracken et al have demonstrated a significant neuroprotective effect of high-dose intravenous (i.v.) methylprednisolone (MP) within 8 h post spinal cord injury (SCI), this practice has recently been challenged. We hypothesized it is possible that acute corticosteroid myopathy (ACM) may occur secondary to the MP. This pilot study was performed to test this hypothesis. Setting: University of Miami School of Medicine/Jackson Memorial Hospital, Miami VA Medical Center, FL, USA. Methods: Subjects included five nonpenetrating traumatic SCI patients, who received 24 h MP according to National Acute Spinal Cord Injury Studies (NASCIS) protocol, and three traumatic patients who suffered SCI and did not receive MP. Muscle biopsies and electromyography (EMG) were performed to determine if myopathic changes existed in these patients. Results: Muscle biopsies from the SCI patients who received 24 h of MP showed muscle damage consistent with ACM in four out of five cases. EMG studies demonstrated myopathic changes in the MP-treated patients. In the three patients who had SCI but did not receive MP, muscle biopsies were normal and EMGs did not reveal evidence of myopathy. Conclusion: Our data suggest that MP in the dose recommended by the NASCIS may cause ACM. If this is true, part of the improvement of neurological recovery showed in NASCIS may be only a recording of the natural recovery of ACM, instead of any protection that MP offers to the injured spinal cord.

KW - Methylprednisolone

KW - Myopathy

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=17444370950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17444370950&partnerID=8YFLogxK

U2 - 10.1038/sj.sc.3101681

DO - 10.1038/sj.sc.3101681

M3 - Article

C2 - 15534623

AN - SCOPUS:17444370950

VL - 43

SP - 199

EP - 203

JO - Spinal Cord

JF - Spinal Cord

SN - 1362-4393

IS - 4

ER -